Posted on 8/16/17
Summit Health Signs Medicare Network Agreement with Humana
CHAMBERSBURG, Pa.--(BUSINESS WIRE)--Summit Health and Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, have signed a new contract that provides in-network . . .
Posted on 8/16/17
MD Magazine and Contagion Expand Strategic Alliance Partnership with Ochsner Health System
CRANBURY, N.J.--(BUSINESS WIRE)--MD Magazine®, a leading online and print source of physician news, conference coverage, and peer-to-peer discussion, and Contagion®, an all-inclusive resource for infectious disease . . .
Posted on 8/15/17
Celsion Corp. Reports Q2 2017 Financial Results and Provides Business Update
LAWRENCEVILLE, N.J., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today announced financial results for the quarter and six month . . .
Posted on 8/15/17
BrainStorm Announces Second Quarter 2017 Financial Results
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced financial results for the second quarter ending June . . .
Posted on 8/15/17
Will Teva Pharmaceuticals Bottom This Time?
After reporting second-quarter results, Teva Pharmaceuticals (TEVA) devastated its shareholders by announcing a dividend cut, writing down part of its Actavis acquisition and issuing a weak . . .
Posted on 8/15/17
Cancer Genetics Acquires vivoPharm
Cancer Genetics, Inc. (Nasdaq: CGIX) and vivoPharm Pty. Ltd. announced today they have entered into a definitive agreement for Cancer Genetics to acquire vivoPharm
Posted on 8/15/17
Cancer Genetics Announces Capital Raise
Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced today financial
Posted on 8/15/17
BioAdvance Commits $4M to 14 Life Sciences Companies
PHILADELPHIA--(BUSINESS WIRE)--BioAdvance announced that it has added eight new companies to its portfolio and made follow-on investments in six of its existing companies. These investments represent . . .
Posted on 8/14/17
Soligenix Receives $2.5M in Additional NIAID Funding
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet
Posted on 8/14/17
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
How many big biotech acquisitions can you name that have occurred so far in 2017?Johnson & Johnson (NYSE:JNJ) spent $30 billion to buy Swiss biotech Actelion. . . .
Posted on 8/14/17
Cancer Treatment Centers of America Named Best Places to Work Finalist
Cancer Treatment Centers of America® (CTCA) at Eastern Regional Medical Center in Philadelphia has been named one of Greater Philadelphia's "Best Places to Work" in the . . .
Posted on 8/13/17
Emisphere Transitions to Non-Reporting Public Company
ROSELAND, N.J., Aug. 11, 2017 (GLOBE NEWSWIRE) -- The Board of Directors of Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that the Company intends to voluntarily terminate . . .
Posted on 8/11/17
Aevi Genomic Medicine Announces Agreement for $28 Million Private Placement
Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") today announced the execution of a definitive agreement to sell shares of common stock and warrants to purchase . . .
Posted on 8/11/17
Intermountain Healthcare Presents Supplier Awards to Johnson & Johnson Medical Devices Companies
The Johnson & Johnson Medical Devices Companies (JJMDC)* have been honored with two supplier awards from Intermountain Healthcare. Intermountain's 2017 Supply Chain Excellence Award was presented . . .
Posted on 8/10/17
Spark Therapeutics Closes Public Offering
PHILADELPHIA, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc.(NASDAQ:ONCE) announced today the closing of the previously announced underwritten public offering of its common stock pursuant . . .
Posted on 8/10/17
Aclaris Announces Proposed Public Offering of Common Stock
MALVERN, Pa., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company, today announced that it intends to offer and sell, subject . . .
Posted on 8/9/17
Why Teva Pharmaceutical and Under Armour Are Looking So Unhealthy
In this segment from Motley Fool Money, host Chris Hill, Million Dollar Portfolio's Jason Moser, Total Income's Ron Gross, and Supernova and Rule Breakers' David Kretzmann . . .
Posted on 8/9/17
Citius Pharmaceuticals Announces Closing of Public Offering
CITIUS PHARMACEUTICALS, INC. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today the closing of its previously . . .
Posted on 8/9/17
Connecticut Children’s Medical Center Selects InstaMed for Seamless and Secure Patient Payments
PHILADELPHIA & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--InstaMed, healthcare’s most trusted payments network, has been selected by Connecticut Children’s Medical Center, a nationally recognized not-for-profit children’s hospital in . . .
Posted on 8/8/17
Precis Engineers Offer Sustainable Guidelines in New Biotechnology Encyclopedia
Precis engineers author chapter, “Addressing Sustainability in Biopharmaceutical Manufacturing Facility Design” in the Encyclopedia of Industrial Biotechnology, published in June.Four engineers from Precis Engineering, Inc. authored the . . .
Posted on 8/8/17
Aramark Reports Third Quarter 2017 Earnings
Aramark (NYSE: ARMK) today reported third quarter fiscal results."Our operating momentum continues as we make consistent progress against our strategic priorities, which led to another quarter . . .
Posted on 8/8/17
Mylan Launches Avonza in India
Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V. (NASDAQ, TASE: MYL), a leading global pharmaceutical company, has received marketing authorization from the Drug Controller General . . .
Posted on 8/8/17
Johnson & Johnson Receives Massive 'No' From Panel: Hope Left?
Recently, Johnson and Johnson (JNJ) drug sirukumab was voted down in an advisory panel. The panel recommended against approval by an overwhelming majority. The main issue . . .
Posted on 8/8/17
Pfizer Highly Recommended By Panel, Time For FDA Showdown
Recently, Pfizer (PFE) received a positive recommendation from a panel for its psoriatic arthritis drug XELJANZ (tofacitinib). The FDA Arthritis Advisory Committee (AAC) voted 10 to . . .
Posted on 8/8/17
Teva Pharmaceuticals - A Deal Too Far?
Teva Pharmaceuticals (TEVA) is officially in crisis mode. Just a year after it completed the purchase of Allergan's (NYSE:AGN) generics business, Teva is under real financial . . .

